According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โน1.280 Trillion. In 2024 the company made a revenue of โน1.218 Trillion an increase over the revenue in the year 2023 that were of โน1.091 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.